SmartCella Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 64

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 12

SmartCella General Information

Description

Developer of a targeted drug delivery platform and endovascular devices designed for localized therapeutic infusion. The company's proprietary catheter technology enables direct injection of payloads into hard-to-reach organs and solid tumors, providing biotechnology and pharmaceutical partners with a modality-agnostic tool to improve therapeutic efficacy and reduce systemic side effects across cardiovascular, oncology, and regenerative medicine applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alfred Nobels Allé 150
  • Tullinge
  • 146 48 Stockholm
  • Sweden
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Alfred Nobels Allé 150
  • Tullinge
  • 146 48 Stockholm
  • Sweden

SmartCella Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SmartCella Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 11-Feb-2025 Completed Generating Revenue
4. Accelerator/Incubator 05-Sep-2024 Completed Generating Revenue
3. Later Stage VC 08-Jul-2024 Completed Generating Revenue
2. Later Stage VC 22-Sep-2021 $49.9M $49.9M Completed Generating Revenue
1. Seed Round Completed Startup
To view SmartCella’s complete valuation and funding history, request access »

SmartCella Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view SmartCella’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SmartCella Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a targeted drug delivery platform and endovascular devices designed for localized therapeutic infusion. The
Drug Delivery
Stockholm, Sweden
64 As of 2025

Solna, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SmartCella Competitors (1)

One of SmartCella’s competitors is Affibody, a Venture Capital-Backed company based in Solna, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Affibody Venture Capital-Backed Solna, Sweden
You’re viewing 1 of 1 competitors. Get the full list »

SmartCella Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SmartCella Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
WorldUpstart Accelerator/Incubator
Swedish-American Chamber of Commerce - New York Accelerator/Incubator
AstraZeneca Corporation Minority
Handelsbankens Fondbolagförvaltning Corporation Minority
RoosGruppen Family Office Minority
You’re viewing 5 of 12 investors. Get the full list »

SmartCella Investments (1)

SmartCella’s most recent deal was a Early Stage VC with Teint for . The deal was made on 18-Apr-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teint 18-Apr-2023 Early Stage VC Personal Products
To view SmartCella’s complete investments history, request access »

SmartCella Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Smartcella Solutions Tullinge, Sweden 2021
Procella Therapeutics Stockholm, Sweden 2018
SmartWise Tullinge, Sweden 2015

SmartCella FAQs

  • When was SmartCella founded?

    SmartCella was founded in 2014.

  • Where is SmartCella headquartered?

    SmartCella is headquartered in Stockholm, Sweden.

  • What is the size of SmartCella?

    SmartCella has 64 total employees.

  • What industry is SmartCella in?

    SmartCella’s primary industry is Drug Delivery.

  • Is SmartCella a private or public company?

    SmartCella is a Private company.

  • What is SmartCella’s current revenue?

    The current revenue for SmartCella is .

  • How much funding has SmartCella raised over time?

    SmartCella has raised $104M.

  • Who are SmartCella’s investors?

    WorldUpstart, Swedish-American Chamber of Commerce - New York, AstraZeneca, Handelsbankens Fondbolagförvaltning, and RoosGruppen are 5 of 12 investors who have invested in SmartCella.

  • Who are SmartCella’s competitors?

    Affibody is a competitor of SmartCella.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process